Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of a Canadian Guidance for reporting real-world evidence for regulatory and health-technology assessment (HTA) decision-making.
Tadrous M, Aves T, Fahim C, Riad J, Mittmann N, Prieto-Alhambra D, Rivera DR, Chan K, Lix LM, Kent S, Dawoud D, Guertin JR, McDonald JT, Round J, Klarenbach S, Stanojevic S, De Vera MA, Strumpf E, Platt RW, Husein F, Lambert L, Hayes KN. Tadrous M, et al. Among authors: rivera dr. J Clin Epidemiol. 2024 Sep 23;176:111545. doi: 10.1016/j.jclinepi.2024.111545. Online ahead of print. J Clin Epidemiol. 2024. PMID: 39322123 Free article.
Feasibility of structuring electronic health record data to facilitate real-world data research: ICAREdata methods applied to multicenter cancer clinical trials.
George S, Campbell N, Hillman SL, Harlos ES, Stein DWJ, Chan MY, Chow SL, Elrahi CL, Quina AC, Kokolus MC, Casagni MD, Weiss M, Anderson DM, Stadler WM, Hoff OC, Rivera DR, Kluetz PG, Mandrekar SJ, Piantadosi S. George S, et al. Among authors: rivera dr. Cancer. 2024 Aug 28. doi: 10.1002/cncr.35528. Online ahead of print. Cancer. 2024. PMID: 39192753
The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system.
Bhimani J, O'Connell K, Persaud S, Blinder V, Burganowski RP, Ergas IJ, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Rivera DR, Roh JM, Tabatabai S, Valice E, Bandera EV, Aiello Bowles EJ, Kushi LH, Kantor ED. Bhimani J, et al. Among authors: rivera dr. Breast Cancer Res Treat. 2024 Nov;208(2):405-414. doi: 10.1007/s10549-024-07433-4. Epub 2024 Aug 16. Breast Cancer Res Treat. 2024. PMID: 39150586
Evaluation of Real-World Tumor Response Derived From Electronic Health Record Data Sources: A Feasibility Analysis in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Chemotherapy.
McKelvey BA, Garrett-Mayer E, Rivera DR, Alabaster A, Andrews HS, Bond EG, Brown TD, Bruno A, Damato L, Espirito JL, Fernandes LL, Hansen E, Kluetz P, Ma X, McCracken A, Mishra-Kalyani PS, Natanzon Y, Potter D, Robert NJ, Schwartz L, Schwind R, Sweetnam C, Wagner J, Stewart MD, Allen JD. McKelvey BA, et al. Among authors: rivera dr. JCO Clin Cancer Inform. 2024 Aug;8:e2400091. doi: 10.1200/CCI.24.00091. JCO Clin Cancer Inform. 2024. PMID: 39146509 Free PMC article.
Patient Characteristics Associated with Intended Nonguideline Chemotherapy in Women with Stage I to IIIA Breast Cancer.
Bhimani J, O'Connell K, Persaud S, Blinder V, Burganowski-Doud RP, Ergas IJ, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Rivera DR, Roh JM, Tabatabai S, Valice E, Bandera EV, Aiello Bowles EJ, Kushi LH, Kantor ED. Bhimani J, et al. Among authors: rivera dr. Cancer Epidemiol Biomarkers Prev. 2024 Oct 2;33(10):1286-1297. doi: 10.1158/1055-9965.EPI-24-0360. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 39051907
Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I-IIIA breast cancer.
Bhimani J, O'Connell K, Persaud S, Blinder V, Burganowski R, Ergas IJ, Foley MJ, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Rivera DR, Roh JM, Tabatabai S, Valice E, Bandera EV, Bowles EJA, Kushi LH, Kantor ED. Bhimani J, et al. Among authors: rivera dr. Int J Cancer. 2024 Nov 1;155(9):1577-1592. doi: 10.1002/ijc.35053. Epub 2024 Jul 6. Int J Cancer. 2024. PMID: 38970396
Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019.
Bhimani J, O'Connell K, Ergas IJ, Foley M, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Persaud S, Rivera DR, Roh JM, Tabatabai S, Valice E, Bowles EJA, Bandera EV, Kushi LH, Kantor ED. Bhimani J, et al. Among authors: rivera dr. Breast Cancer Res. 2024 Jun 13;26(1):101. doi: 10.1186/s13058-024-01822-9. Breast Cancer Res. 2024. PMID: 38872192 Free PMC article.
87 results